Characteristics of Systemic Lupus Erythematosus
The following are established features of SLE: pleuritis (a), non-scarring alopecia (b), Raynaud's phenomenon (c), and photosensitivity with disease exacerbation following sun exposure (e), while erosive joint lesions similar to RA (d) are NOT typical of classic SLE.
Detailed Analysis of Each Feature
a) Pleuritis - TRUE
Pleuritis (serositis) is a well-recognized manifestation of SLE and is included in disease activity monitoring indices such as BILAG, ECLAM, and SLEDAI 11. Serositis represents one of the clinical manifestations that correlates with disease severity and is used in routine clinical evaluation of SLE patients.
b) Non-scarring Alopecia - TRUE
Non-scarring alopecia is a highly characteristic feature of SLE, occurring in 86.67% of patients in one study 2 and 40% in another 3. This type of hair loss is so specific to systemic lupus that it has been regarded as a diagnostic criterion for SLE 4. The guideline evidence confirms that new clinical manifestations including alopecia correlate with disease severity and can predict future flares 111.
Key distinction: Non-scarring alopecia is the typical SLE pattern, whereas scarring alopecia occurs with chronic discoid lupus lesions (a subset of cutaneous LE).
c) Raynaud's Phenomenon - TRUE
Raynaud's phenomenon occurs in 40-60% of SLE patients 56. Multiple studies confirm this as a genuine SLE manifestation, though interestingly, it is associated with a milder disease phenotype and better prognosis 5. Patients with Raynaud's phenomenon in SLE have greater incidence of arthritis, malar rash, and photosensitivity, but lesser incidence of severe renal disease and lower mortality rates 56.
d) Erosive Joint Lesions (Similar to RA) - FALSE
This is the critical distinction: Traditional teaching holds that SLE arthritis is non-erosive, which differentiates it from rheumatoid arthritis. However, recent evidence using high-resolution imaging has challenged this somewhat, showing that up to 40% of SLE patients with joint involvement can develop erosive damage 7.
Important caveat: Despite this newer data, erosive arthritis is NOT considered a typical or characteristic feature of classic SLE. When present, it suggests either:
- Overlap syndrome with RA (Rhupus)
- A more aggressive SLE phenotype requiring RA-like treatment
- The presence of anti-citrullinated protein antibodies
The 2012 SLICC classification criteria notably changed the old definition from "non-erosive arthritis" to "synovitis or tenderness" specifically to acknowledge this possibility, but erosive disease remains atypical 7.
e) Photosensitivity with Disease Exacerbation - TRUE
Photosensitivity is a hallmark of SLE, occurring in 50-63% of patients 23. UV radiation is a well-acknowledged triggering factor for both cutaneous and systemic lupus flares 88. The evidence is so strong that EULAR guidelines specifically recommend photoprotection for prevention of flares, including avoidance of direct sun exposure, use of physical barriers (hats, sunglasses, long-sleeved clothing), and broad-spectrum sunscreens 88. Double-blind studies have demonstrated that sunscreens can prevent development of skin lesions following photoprovocation 11.
Clinical Implications
When evaluating a patient for SLE, the presence of pleuritis, non-scarring alopecia, Raynaud's phenomenon, and photosensitivity all support the diagnosis. These manifestations are included in disease activity monitoring and can predict flares 111.
If erosive joint lesions are present, consider:
- Overlap with RA (check anti-CCP antibodies, rheumatoid factor)
- More aggressive immunosuppressive therapy as recommended by 2019 EULAR guidelines for RA-like moderate arthritis 9
- This represents a distinct phenotype requiring different management than typical SLE arthritis
Answer: a, b, c, and e are characteristic features; d is NOT typical of SLE